Clinical Trial

Predicting DBS Outcomes in Dystonia Using Wearable Gait Sensors

Recruiting
View on ClinicalTrials.gov →
Summary
This study aims to investigate whether preoperative gait characteristics, measured by wearable sensors, can predict the clinical outcomes of Deep Brain Stimulation (DBS) in patients with dystonia. Participants scheduled for DBS surgery will undergo gait analysis using wearable sensors before the procedure. Clinical assessments, including the Burke-Fahn-Marsden Dystonia Rating Scale (BFMDRS) and the SF-36 Health Survey, will be conducted preoperatively and postoperatively to evaluate surgical efficacy and quality of life. The study seeks to identify gait biomarkers that correlate with optimal DBS response.
Trial Details
NCT Number NCT07323602
Lead Sponsor Ruijin Hospital
Collaborators: Suzhou Sceneray Medical Co. , Ltd, Beijing Pins Medical Co., Ltd, Medtronic
Conditions Dystonia
Enrollment 50 participants
Start Date 2025-08-01
Primary Completion 2029-12 (estimated)
Study Completion 2029-12 (estimated)
Updated on ClinicalTrials.gov 2026-01-07